Transurethral coagulation for radiation-induced hemorrhagic cystitis using Greenlight™ potassium-titanyl-phosphate laser

Photomed Laser Surg. 2013 Feb;31(2):78-81. doi: 10.1089/pho.2012.3396. Epub 2013 Jan 17.

Abstract

Objective: The aim of this study was to to demonstrate the initial treatment outcomes of Greenlight™ potassium-titanyl-phosphate (KTP) laser on radiation-induced hemorrhagic cystitis.

Background data: Hemorrhagic cystitis is a common complication of radiation therapy for pelvic tumors.

Materials and methods: From September 2004 to February 2011, 10 patients with radiation-induced intractable hemorrhagic cystitis underwent transurethral Greenlight KTP laser coagulation of the bladder. The power setting was limited to 20-30 W.

Results: Bleeding stopped in all cases after one session of laser treatment. Mean follow-up time was 17 months (6-36 months). All patients underwent cystoscopy 3 months postoperatively, and no bleeding or significant scar was found. Recurrence of significant bleeding was seen in one case 7 months post-operation, and was again cured by KTP laser. There were no complications from the procedures.

Conclusions: Our experience suggests that transurethral coagulation using KTP laser is a safe and effective strategy for the treatment of hemorrhagic radiation cystitis.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cystitis / etiology
  • Cystitis / radiotherapy*
  • Female
  • Humans
  • Laser Coagulation / methods*
  • Lasers, Solid-State / therapeutic use*
  • Male
  • Middle Aged
  • Prostatic Neoplasms / radiotherapy
  • Radiation Injuries
  • Urinary Bladder / injuries
  • Urinary Bladder / radiation effects*
  • Urinary Bladder Neoplasms / radiotherapy
  • Uterine Cervical Neoplasms / radiotherapy